Latest 10-K annual reports

NASDAQ
Cloudastructure, an AI-powered security solutions provider, reported significant revenue growth in 2025 but continued to incur substantial net losses, facing Nasdaq delisting concerns.
NASDAQ
Aureus Greenway Holdings Inc. reported a significant net loss in 2025 due to declining revenues and soaring operating costs, despite completing major renovations and securing new financing.
NASDAQ
Idea Acquisition Corp.'s 2025 10-K filing outlines its blank check company structure, IPO details, and strategic intent to acquire an AI/blockchain infrastructure company.
NASDAQ
HCW Biologics Inc. reported significant losses and a material weakness in internal controls, raising substantial doubt about its ability to continue as a going concern, despite progress in clinical trials and recent capital raises.
AMEX
American Shared Hospital Services reports a net loss for 2025 and faces substantial doubt about its ability to continue as a going concern due to multiple debt covenant defaults.
NASDAQ
Dawson Geophysical Company reported a reduced net loss of $1.9 million in 2025, an improvement from $4.1 million in 2024, driven by increased demand and strategic equipment investments.
Universal Token, Inc. filed its annual 10-K report for 2025, revealing no revenue, increased net losses, and a going concern warning, despite progress in software development and capital raises.
OTC.Pink
PAID Inc. reported an 11% revenue increase in 2025, driven by shipping services, but posted a net loss due to higher operating expenses and reduced other income.
Crown PropTech Acquisitions, a blank check company, reported substantial doubt about its ability to continue as a going concern following delisting from NYSE, significant shareholder redemptions, and ongoing delays in its business combination with Mkango Rare Earths Limited.
NASDAQ
ENDRA Life Sciences reported a net loss of $7.03 million for 2025, faces substantial doubt about its ability to continue as a going concern, and is evaluating strategic alternatives while delaying its key FDA submission.
AMEX
Nuburu, Inc. is undergoing a significant strategic transformation, shifting its focus from industrial lasers to a dual-use defense and security platform through key acquisitions and joint ventures.
NASDAQ
Alpha Cognition Inc. commercially launched its Alzheimer's treatment ZUNVEYL, generating initial revenue, but reported a significant increase in net losses for the fiscal year ended December 31, 2025.
NASDAQ
Edible Garden AG Incorporated reported a significant net loss for 2025, driven by strategic shifts into ready-to-drink beverages and elevated costs, while facing ongoing going concern doubts.
NASDAQ
Alset Inc. announced a substantial net loss of $49.35 million in 2025, a significant increase from the prior year, driven by an 86% drop in real estate revenue and a major equity investment impairment.
NASDAQ
Fortress Biotech significantly reduced its net loss in 2025, driven by strategic asset monetizations and product approvals, despite ongoing operating losses and a paused preferred stock dividend.
Decoy Therapeutics Inc. reports a significant net loss for 2025, addresses Nasdaq delisting concerns with a reverse stock split, and advances its AI-driven peptide conjugate pipeline following a strategic merger.
NASDAQ
Femasys Inc. reported continued operating losses and substantial doubt about its ability to continue as a going concern, alongside Nasdaq delisting notices, despite increased sales and product development progress.
OQB
ADM Endeavors, Inc. reported increased net income for fiscal year 2025 despite a slight revenue decrease, driven by operational efficiencies and strategic asset sales.
NASDAQ
Kodiak Sciences reports significant clinical trial advancements for its retinal disease pipeline, including successful Phase 3 studies for Zenkuda, alongside substantial net losses and going concern doubt.
OTC.Pink
Scientific Industries, Inc. reported a significantly reduced net loss for fiscal year 2025, driven by the sale of its Genie product line and continued investment in its Bioprocessing Systems segment.
NASDAQ
Callan JMB Inc. reported a significant net loss of $7.97 million for 2025, a substantial increase from the prior year, alongside a 13% drop in revenue.
AMEX
CPI Aerostructures, Inc. reported a significant net loss in 2025, primarily due to the termination of the Boeing A-10 Main Landing Gear Pods program and reduced government contract revenue.
OTC.Pink
American Rebel Holdings, Inc. reported a significant increase in net loss for 2025, driven by slower sales and substantial debt extinguishment losses, while pursuing diversification into beverages and real estate.
NASDAQ
TMC the metals company Inc. details significant progress in deep-sea polymetallic nodule development, including U.S. regulatory advancements, strategic partnerships, and financial results for the fiscal year ended December 31, 2025.
NYSE
Copley Acquisition Corp's 2025 annual report highlights a net income of $4.13 million but raises substantial doubt about its ability to continue as a going concern due to insufficient liquidity.
NASDAQ
XCF Global, Inc. reports significant operating losses and liquidity challenges, raising substantial doubt about its ability to continue as a going concern, despite strategic acquisitions and a focus on sustainable aviation fuel production.
OID
Revium Rx, a preclinical biopharmaceutical company, reported a significant net loss of $13.4 million in 2025 and faces substantial doubt about its ability to continue as a going concern, compounded by a dispute over its Nano-Candesartan license.
NASDAQ
AirSculpt Technologies reports a 15.8% revenue decline and increased net losses in 2025, alongside a material weakness in internal controls.
Cycurion, Inc. reported a significant net loss of $24.06 million for fiscal year 2025, driven by business combination expenses and increased public company costs, alongside a 14.8% revenue decrease, while actively managing Nasdaq listing compliance and pursuing strategic growth initiatives.
NASDAQ
Flushing Financial Corporation filed an amended annual report to update corporate governance details, executive compensation, and affirm strong 2025 financial performance ahead of its merger with OceanFirst Financial Corp.